Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Jubilant Pharmova Gains 6%; BSE HEALTHCARE Index Up 0.2%
Thu, 1 Aug 9:50

Jubilant Pharmova Gains 6%; BSE HEALTHCARE Index Up 0.2%Image source: phive2015/www.istockphoto.com

Jubilant Pharmova share price has zoomed 6% and is presently trading at Rs 816.0.

Meanwhile, the BSE HEALTHCARE index is at 40,615.3 (up 0.2%).

Among the top gainers in the BSE HEALTHCARE index today are ASTER DM HEALTHCARE (up 4.6%) and SYNGENE INTERNATIONAL (up 2.4%).

Pfizer (down 1.1%) and J.B.Chemicals (down 1.0%) are among the top losers today.

Over the last one year, Jubilant Pharmova has moved up from Rs 377.5 to Rs 816.0, registering a gain of Rs 438.6 (up 116.2%).

On the other hand, the BSE HEALTHCARE index has moved up from 27,736.5 to 40,615.3, registering a gain of 46.4% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 116.2%), SUVEN PHARMACEUTICALS (up 100.9%) and Cadila Healthcare (up 99.1%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 82,016.6 (up 0.3%).

The top gainers among the BSE Sensex today are Maruti Suzuki (up 2.7%) and MUNDRA PORT & SEZ (up 2.0%). The most traded stocks in the BSE Sensex are Tata Steel and NTPC.

In the meantime, NSE Nifty is at 25,044.4 (up 0.4%). Maruti Suzuki and Coal India are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 66,527.7 to 82,016.6, registering a gain of 15,488.9 points (up 23.3%).

Jubilant Pharmova Financial Update...

Jubilant Pharmova net profit grew 6410.8% YoY to Rs 4,818 million for the quarter ended June 2024, compared to a profit of Rs 74 million a year ago. Net sales rose 9.1% to Rs 17,317 million during the period as against Rs 15,869 million in April-June 2023.

For the year ended March 2023, Jubilant Pharmova reported 115.7% decrease in net profit to Rs -649 million compared to net profit of Rs 4,130 million during FY22. Revenue of the company grew 2.5% to Rs 62,817 million during FY23.

The current Price to earnings ratio of Jubilant Pharmova, based on rolling 12 month earnings, stands at 24.9.


Equitymaster requests your view! Post a comment on "Jubilant Pharmova Gains 6%; BSE HEALTHCARE Index Up 0.2%". Click here!